Lv53
950 积分 2025-08-28 加入
[Expert consensus on intravesical therapy for non-muscle invasive bladder cancer (2025 edition)]
18天前
已完结
Market watch: Forecasting market share in the US pharmaceutical market
27天前
已完结
The Lancet Breast Cancer Commission
27天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
3个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
5个月前
已完结
[Analysis of epidemiological trends from 1990 to 2021 of liver cancer in China]
5个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
5个月前
已完结
Cardiac positron emission tomography and other modalities for coronary artery disease assessment: A snapshot from the medicare data
6个月前
已关闭